Eversept Partners, LP
- SEC CIK
- 0001697013
- Latest filing
- Aug 14, 2026
Holdings in Q1 2026
Holdings as of Mar 31, 2026, filed May 15, 2026. Long positions only; changes compare share counts with Q4 2025.
- Positions
- 104
- +1 vs. Q4 2025
- Portfolio value
- $1.52B
- −$266.0M (−14.9%) vs. Q4 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| UTHRUnited Therapeutics Corp | COM | 264,271 | $156.7M | 10.3% | +11,679+4.6% | Added | History |
| ABVXAbivax S.A. | SPONSORED ADS | 934,423 | $104.0M | 6.9% | +276,589+42.0% | Added | History |
| GSKGSK plc | ADR | 1,785,175 | $98.5M | 6.5% | −894,546−33.4% | Reduced | History |
| VERAVera Therapeutics, Inc. | CL A | 2,173,286 | $87.4M | 5.8% | −899,018−29.3% | Reduced | History |
| NTRANatera, Inc. | COM | 384,713 | $76.9M | 5.1% | +50,220+15.0% | Added | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 2,885,622 | $67.4M | 4.4% | −428,786−12.9% | Reduced | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 1,788,016 | $56.7M | 3.7% | +353,291+24.6% | Added | History |
| PCVXVaxcyte, Inc. | COM | 924,193 | $53.7M | 3.5% | −273,529−22.8% | Reduced | History |
| BKDBrookdale Senior Living Inc. | COM | 3,568,555 | $48.8M | 3.2% | +3,193,626+851.8% | Added | History |
| IONSIonis Pharmaceuticals Inc | COM | 632,100 | $47.5M | 3.1% | +93,882+17.4% | Added | History |
| HCAHCA Healthcare, Inc. | COM | 79,229 | $37.5M | 2.5% | −16,645−17.4% | Reduced | History |
| WELLWelltower Inc. | REIT | 180,953 | $35.8M | 2.4% | +180,953 | New | History |
| DOCHealthpeak Properties, Inc. | COM | 1,981,070 | $32.5M | 2.1% | +1,981,070 | New | History |
| PODDInsulet Corp | Stock | 143,546 | $30.1M | 2.0% | +68,838+92.1% | Added | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 3,039,820 | $28.9M | 1.9% | +46,925+1.6% | Added | History |
| GERNGeron Corp | COM | 18,834,883 | $28.1M | 1.8% | +1,174,900+6.7% | Added | History |
| OHIOmega Healthcare Investors Inc | COM | 585,680 | $25.7M | 1.7% | +585,680 | New | History |
| LQDALiquidia Corp | COM NEW | 677,392 | $25.6M | 1.7% | +167,949+33.0% | Added | History |
| CYHCommunity Health Systems Inc | COM | 8,677,281 | $25.5M | 1.7% | +733,479+9.2% | Added | History |
| AVTRAvantor, Inc. | COM | 2,974,287 | $23.3M | 1.5% | −202,357−6.4% | Reduced | History |
| QGENQiagen N.V. | ORD SHARES | 545,330 | $21.8M | 1.4% | +545,330 | New | History |
| EHCEncompass Health Corp | COM | 194,104 | $18.8M | 1.2% | +87,178+81.5% | Added | History |
| LLYEli Lilly & Co | Stock | 19,000 | $17.5M | 1.2% | +8,377+78.9% | Added | History |
| TVTXTravere Therapeutics, Inc. | COM | 542,610 | $16.1M | 1.1% | −632,358−53.8% | Reduced | History |
| CTMXCytomX Therapeutics, Inc. | COM | 3,188,514 | $15.0M | 1.0% | +681,424+27.2% | Added | History |
| RGENRepligen Corp | COM | 120,785 | $14.2M | 0.9% | +120,785 | New | History |
| BBNXBeta Bionics, Inc. | COM | 1,414,838 | $14.2M | 0.9% | +736,576+108.6% | Added | History |
| VRDNViridian Therapeutics, Inc. | COM | 713,269 | $14.0M | 0.9% | −1,068,966−60.0% | Reduced | History |
| ARQTArcutis Biotherapeutics, Inc. | COM | 576,580 | $13.6M | 0.9% | +141,946+32.7% | Added | History |
| ARDXArdelyx, Inc. | COM | 2,229,446 | $13.4M | 0.9% | +514,317+30.0% | Added | History |
| LTCLTC Properties Inc | REIT | 321,046 | $11.9M | 0.8% | +321,046 | New | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 207,768 | $11.7M | 0.8% | +114,020+121.6% | Added | History |
| CHEChemed Corp | COM | 31,057 | $11.7M | 0.8% | +31,057 | New | History |
| PHVSPharvaris N.V. | COM | 406,960 | $11.5M | 0.8% | −32,217−7.3% | Reduced | History |
| PNTGPennant Group, Inc. | COM | 312,178 | $9.52M | 0.6% | +18,218+6.2% | Added | History |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 285,764 | $9.15M | 0.6% | −135,063−32.1% | Reduced | History |
| PALIPalisade Bio, Inc. | COM | 4,987,499 | $8.73M | 0.6% | −404,049−7.5% | Reduced | History |
| MRNAModerna, Inc. | Stock | 159,708 | $8.11M | 0.5% | −108,115−40.4% | Reduced | History |
| VKTXViking Therapeutics, Inc. | COM | 239,110 | $7.78M | 0.5% | +239,110 | New | History |
| ICLRIcon PLC | COM | 68,688 | $7.60M | 0.5% | −27,144−28.3% | Reduced | History |
| XENEXenon Pharmaceuticals Inc. | COM | 129,574 | $7.53M | 0.5% | −101,806−44.0% | Reduced | History |
| RVTYRevvity, Inc. | COM | 84,854 | $7.43M | 0.5% | −77,923−47.9% | Reduced | History |
| AGIOAgios Pharmaceuticals, Inc. | COM | 200,000 | $6.77M | 0.4% | +200,000 | New | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 138,036 | $6.65M | 0.4% | +10,475+8.2% | Added | History |
| TECHBIO-TECHNE Corp | COM | 125,896 | $6.58M | 0.4% | −251,509−66.6% | Reduced | History |
| GKOSGLAUKOS Corp | COM | 60,214 | $6.48M | 0.4% | −87,257−59.2% | Reduced | History |
| THCTenet Healthcare Corp | COM NEW | 29,512 | $5.57M | 0.4% | +29,512 | New | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 10,000 | $5.23M | 0.3% | +10,000 | New | History |
| ISRGIntuitive Surgical Inc | COM NEW | 11,119 | $5.13M | 0.3% | −6,943−38.4% | Reduced | History |
| ESPREsperion Therapeutics, Inc. | COM | 1,735,963 | $4.76M | 0.3% | −2,115,170−54.9% | Reduced | History |
| MOHMolina Healthcare, Inc. | COM | 32,811 | $4.37M | 0.3% | −12,659−27.8% | Reduced | History |
| HQYHealthequity, Inc. | COM | 51,614 | $4.31M | 0.3% | −134,125−72.2% | Reduced | History |
| BRKRBruker Corp | COM | 117,013 | $4.23M | 0.3% | −666,776−85.1% | Reduced | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 183,902 | $3.94M | 0.3% | +183,902 | New | History |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 677,924 | $3.75M | 0.2% | +677,924 | New | History |
| CNCCentene Corp | Stock | 111,652 | $3.66M | 0.2% | −212,440−65.5% | Reduced | History |
| GRCEGrace Therapeutics, Inc. | CL A | 756,600 | $3.50M | 0.2% | +756,600 | New | History |
| ENGNenGene Therapeutics Inc. | COM | 510,543 | $3.48M | 0.2% | +54,708+12.0% | Added | History |
| EHABEnhabit, Inc. | COM | 227,451 | $3.20M | 0.2% | +8,941+4.1% | Added | History |
| DFTXDefinium Therapeutics, Inc. | COM SHS | 160,723 | $3.04M | 0.2% | +160,723 | New | History |
| EQEquillium, Inc. | COM | 1,498,993 | $3.00M | 0.2% | +1,498,993 | New | History |
| ENSGEnsign Group, Inc | COM | 14,761 | $2.97M | 0.2% | +14,761 | New | History |
| IVVDInvivyd, Inc. | COM | 2,276,349 | $2.96M | 0.2% | +136,219+6.4% | Added | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 2,348,360 | $2.91M | 0.2% | +2,348,360 | New | History |
| ALECAlector, Inc. | COM | 1,351,106 | $2.90M | 0.2% | +344,943+34.3% | Added | History |
| ANROAlto Neuroscience, Inc. | COM SHS | 125,168 | $2.81M | 0.2% | +125,168 | New | History |
| RLAYRelay Therapeutics, Inc. | COM | 270,705 | $2.69M | 0.2% | −218,432−44.7% | Reduced | History |
| REPLReplimune Group, Inc. | COM | 334,861 | $2.56M | 0.2% | +334,861 | New | History |
| LBRXLB Pharmaceuticals Inc | COM SHS | 100,198 | $2.47M | 0.2% | +100,198 | New | History |
| LPCNLipocine Inc. | COM NEW | 294,989 | $2.36M | 0.2% | +294,989 | New | History |
| VIRVir Biotechnology, Inc. | COM | 250,000 | $2.24M | 0.1% | +250,000 | New | History |
| AVRAnteris Technologies Global Corp. | COM | 401,187 | $2.23M | 0.1% | −98,813−19.8% | Reduced | History |
| AMRNAmarin Corp PLC | SPONSORED ADR | 147,715 | $2.14M | 0.1% | −24,473−14.2% | Reduced | History |
| SVRASavara Inc | COM | 384,264 | $2.10M | 0.1% | +214,069+125.8% | Added | History |
| RLMDRelmada Therapeutics, Inc. | COM | 277,899 | $1.93M | 0.1% | +277,899 | New | History |
| CTNMContineum Therapeutics, Inc. | CL A | 146,411 | $1.91M | 0.1% | +8,918+6.5% | Added | History |
| STROSutro Biopharma, Inc. | COM SHS | 73,161 | $1.82M | 0.1% | −120,410−62.2% | Reduced | History |
| INOInovio Pharmaceuticals, Inc. | COM SHS | 1,035,360 | $1.80M | 0.1% | +1,035,360 | New | History |
| SRZNSurrozen, Inc. | COM NEW | 58,624 | $1.71M | 0.1% | −36,662−38.5% | Reduced | History |
| IFRXInflaRx N.V. | COM | 1,758,573 | $1.57M | 0.1% | +1,261+0.1% | Added | History |
| KPTIKaryopharm Therapeutics Inc. | COM NEW | 276,174 | $1.54M | 0.1% | +276,174 | New | History |
| ANABAnaptysbio, Inc | COM | 27,089 | $1.50M | 0.1% | −93,838−77.6% | Reduced | History |
| NVCRNovoCure Ltd | ORD SHS | 134,917 | $1.47M | 0.1% | +13,939+11.5% | Added | History |
| BVSBioventus Inc. | COM CL A | 159,110 | $1.45M | 0.1% | −312,147−66.2% | Reduced | History |
| AGLagilon health, inc. | COM NEW | 176,588 | $1.40M | 0.1% | +176,588 | New | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 62,575 | $1.31M | 0.1% | −254,607−80.3% | Reduced | History |
| EVMNEvommune, Inc. | COM SHS | 54,680 | $1.26M | 0.1% | +54,680 | New | History |
| IMCRImmunocore Holdings plc | ADS | 39,238 | $1.18M | 0.1% | +39,238 | New | History |
| ASMBAssembly Biosciences, Inc. | COM NEW | 40,889 | $1.13M | 0.1% | −118,787−74.4% | Reduced | History |
| PLRXPliant Therapeutics, Inc. | COM | 891,425 | $1.12M | 0.1% | +49,402+5.9% | Added | History |
| SPRYARS Pharmaceuticals, Inc. | COM | 136,235 | $1.09M | 0.1% | −115,358−45.9% | Reduced | History |
| WHWKWhitehawk Therapeutics, Inc. | COM | 306,800 | $1.06M | 0.1% | +46,541+17.9% | Added | History |
| TYRATyra Biosciences, Inc. | COM | 27,055 | $1.04M | 0.1% | −251,509−90.3% | Reduced | History |
| PASGPassage BIO, Inc. | COM | 131,581 | $1.03M | 0.1% | +5,351+4.2% | Added | History |
| DHCDiversified Healthcare Trust | COM SH BEN INT | 151,283 | $1.00M | 0.1% | +151,283 | New | History |
| INMDInMode Ltd. | SHS | 67,744 | $926.7K | 0.1% | +5,806+9.4% | Added | History |
| SNDASonida Senior Living, Inc. | COM | 28,437 | $917.1K | 0.1% | +28,437 | New | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 190,715 | $884.9K | 0.1% | +11,800+6.6% | Added | History |
| EDITEditas Medicine, Inc. | COM | 290,919 | $718.6K | <0.1% | 00.0% | Unchanged | History |
| SSIISS Innovations International, Inc. | COM NEW | 110,157 | $550.8K | <0.1% | +34,799+46.2% | Added | History |
Options (16)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| Invesco QQQ Trust Series I46090E103 | ETF | $137.8M | – |
| SPYSPDR S&P 500 ETF Trust | ETF | $69.6M | – |
| VRTXVertex Pharmaceuticals Inc | Stock | – | $40.2M |
| iShares Tr464287432 | 20 YR TR BD ETF | $37.2M | – |
| QGENQiagen N.V. | ORD SHARES | – | $19.1M |
| INSMINSMED Inc | COM PAR $.01 | – | $15.4M |
| iShares Tr464288513 | IBOXX HI YD ETF | $14.3M | – |
| UNHUnitedHealth Group Inc | Stock | – | $10.8M |
| iShares Russell 2000 ETF464287655 | ETF | $9.92M | – |
| State Street Technology Select Sector SPDR ETF81369Y803 | ETF | $9.30M | – |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | $4.77M | – |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $3.83M | – |
| UHSUniversal Health Services Inc | CL B | $3.26M | – |
| State Street Energy Select Sector SPDR ETF81369Y506 | ETF | – | $3.06M |
| REPLReplimune Group, Inc. | COM | – | $397.8K |
| KPTIKaryopharm Therapeutics Inc. | COM NEW | – | $132.6K |
Sold out since Q4 2025 (31)
Positions held at the end of Q4 2025 that are gone from this filing.
| Security | Class | Shares in Q4 2025 | Value in Q4 2025 | % of portfolio in Q4 2025 | History |
|---|---|---|---|---|---|
| DHRDanaher Corp | Stock | 186,262 | $42.6M | 2.4% | History |
| EXASExact Sciences Corp | COM | 241,678 | $24.5M | 1.4% | History |
| CDTXCidara Therapeutics, Inc. | COM NEW | 98,721 | $21.8M | 1.2% | History |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 660,177 | $20.6M | 1.2% | History |
| UNHUnitedHealth Group Inc | Stock | 60,862 | $20.1M | 1.1% | History |
| BIIBBiogen Inc. | COM | 77,944 | $13.7M | 0.8% | History |
| SEMSelect Medical Holdings Corp | COM | 906,100 | $13.5M | 0.8% | History |
| CGONCG Oncology, Inc. | COM | 308,466 | $12.8M | 0.7% | History |
| BMYBristol Myers Squibb Co | Stock | 235,293 | $12.7M | 0.7% | History |
| ELVElevance Health, Inc. | Stock | 30,195 | $10.6M | 0.6% | History |
| MNKDMannkind Corp | COM NEW | 1,852,563 | $10.5M | 0.6% | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 48,241 | $10.3M | 0.6% | History |
| ILMNIllumina, Inc. | COM | 76,721 | $10.1M | 0.6% | History |
| DVAXDynavax Technologies Corp | COM NEW | 605,976 | $9.32M | 0.5% | History |
| EWTXEdgewise Therapeutics, Inc. | COM | 337,340 | $8.37M | 0.5% | History |
| CPRXCatalyst Pharmaceuticals, Inc. | COM | 358,168 | $8.36M | 0.5% | History |
| HUMHumana Inc | Stock | 32,462 | $8.31M | 0.5% | History |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 10,097 | $7.79M | 0.4% | History |
| CVSCVS Health Corp | Stock | 63,696 | $5.05M | 0.3% | History |
| ACADAcadia Pharmaceuticals Inc | COM | 176,594 | $4.72M | 0.3% | History |
| PTGXProtagonist Therapeutics, Inc | COM | 52,961 | $4.63M | 0.3% | History |
| ZBIOZenas BioPharma, Inc. | COM | 121,016 | $4.39M | 0.2% | History |
| NHCNational Healthcare Corp | COM | 28,577 | $3.92M | 0.2% | History |
| FTREFortrea Holdings Inc. | COMMON STOCK | 224,139 | $3.87M | 0.2% | History |
| MRVIMaravai Lifesciences Holdings, Inc. | COM CL A | 718,582 | $2.34M | 0.1% | History |
| EOLSEvolus, Inc. | COM | 344,104 | $2.29M | 0.1% | History |
| RAPPRapport Therapeutics, Inc. | COM | 59,233 | $1.80M | 0.1% | History |
| BHVNBiohaven Ltd. | COM | 145,431 | $1.64M | 0.1% | History |
| QUREuniQure N.V. | SHS | 62,820 | $1.50M | 0.1% | History |
| NVAXNovavax Inc | COM NEW | 181,220 | $1.22M | 0.1% | History |
| CBLLCeribell, Inc. | COM | 17,094 | $374.9K | <0.1% | History |